InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Saturday, 12/03/2022 8:07:03 AM

Saturday, December 03, 2022 8:07:03 AM

Post# of 425928
Large scale Infringement on Amarin's CVD patents is being facilitated by generic companies and insurance companies...This is due to flaws in the HW patent law, which will not be fixed by congress any time soon.

IMHO Amarin's best course of action is to concentrate its attention and cash on getting approval of new patented drugs, such as MND-2119 or a FDC with a statin and NMD-2119....and stop swimming against the tide with lawsuits, which are destined not to succeed...at least, not to succeed in a timely fashion to help Vascepa.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News